Scott Rocklage began working for 5AM Ventures in the year 2003 as a partner. He later on became the company’s managing partner in the year 2004. Scott Rocklage has worked with various organizations such as: Cubist Pharmaceuticals where he was the chief executive officer, Nycomed Salutar where he was the chief executive.
Scott Rocklage was also the Chairman at Relypsa and Novira. Through his years of working he is now working in Rennoiva, Kinestral and Cidara as the chairman of the board.
Scott Rocklage went to the University of California, where he obtained a BSc. Chemistry, he also went to Massachusetts Institute of Technology and acquired a PhD in Chemistry, while studying in Massachusetts, he won a Nobel Prize, and he frequented the laboratory of Richard R.Schrock where he did his research. Scott has had experience for over 20 years in healthcare and he also has good leadership skills.
Scott Rocklage is also the chairman of Kinesrtal, Rennovia and Cidara Therapeutics. He also heads the board of Pulmatrix and Epirus. Due to Scott’s skills and experience, he has been managed to get the approval of new medicines in United States by FDA.
Scott Rocklage has managed to get many publications that are under his name. 5 AM Ventures as a firm is involved in development of life sciences. 5 AM Ventures is given this name because it deals with the formation of companies at an early stage.
After Scott Rocklage got the position of managing partner, he got various responsibilities such as: to attend board meetings, to participate in the development of new life science concepts and to go hand in hand with the company’s portfolio and team management.
Scott Rocklage also works with other various people such as scientists, physicians and business executives where he works with them by assisting them to advance their ideas.
The skills and experience of Scott have helped 5AM Ventures to be the best successful company in terms of a Venture Capital company for other companies that want to be involved in life science. His contribution in the field of health care innovation has been tremendous.
Learn more about Nathaniel Ru: